COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights.
Affluent Medical announces availability of a prospectus for trading of 6,190,831 shares in connection with a capital increase without preferential subscription rights. The AMF-approved Prospectus includes details of the Capital Increase -
COMMUNIQUÉ DE PRESSE
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
Affluent Medical announces a capital increase without preferential subscription rights involving the trading of 6,190,831 shares. Edwards Lifesciences becomes a 9.21% shareholder after subscribing for €5 million. Risk factors are highlighted in the available prospectus -
-
-
COMMUNIQUÉ DE PRESSE
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences, focusing on innovative medical devices and structural heart products -
COMMUNIQUÉ DE PRESSE
Affluent Medical conclut des accords sur ses technologies de valve mitrale moyennant un paiement initial de 15 millions d'euros.
Affluent Medical conclut des accords pour ses technologies de valve mitrale avec un paiement initial de 15 millions d'euros. L'entreprise recevra des paiements pour son annexe et sa technologie de valve, ainsi qu'une participation au capital -
-
-
